PD Therapeutics Market Potential Reviewed in New GlobalData Research Study Published at MarketPublishers.com
19 Apr 2012 • by Natalie Aster
LONDON – Posting a CAGR of 5.8% from 2002 to 2011, the global Parkinson’s disease (PD) therapeutics market was worth USD 2,992 million last year. The market size was chiefly driven by two the increase in PD prevalence due to the rise in the aging population in the eleven key markets and the surging cost of therapy.
By 2020, the worldwide PD therapeutics market is forecast to reach USD 3,650 million growing at a CAGR of 2.2%, with the modest growth rate attributed to patent expiries of the major drugs, the subsequent entry of generics and the weak late-stage developmental pipeline. The major drugs, which are expected go off patent during the forecast period are Azilect, Comtan, Stalevo, Tasmar, Mirapex ER and Requip XL, of which the impact is expected to be partially adjusted by the introduction of new drugs such as IPX 066, preladenant and safinamide during 2011-2020.
New research study “Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020” developed by GlobalData has been recently published by Market Publishers Ltd.
Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
Published: January, 2012
Price: US$ 6.995,00
The report delves into extensive research and analysis of the global Parkinson’s disease therapeutics market. It highlights the treatment guidelines and identifies the key trends shaping and driving the market globally; analyzes treatment usage patterns and provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the market leaders. Furthermore, the study provides valuable insights into the pipeline products and quantifies the unmet need within the worldwide PD therapeutics market as well as in the individual markets of the US and the top five countries in Europe, highlighting opportunities for future players.
Key geographies covered include: the US, the UK, Italy, Spain, Germany, France, Japan, Brazil, Russia, India, and China.
Key future market players mentioned are: Merck & Co, Impax Laboratories, Acadia Pharmaceuticals, Newron Pharmaceuticals, and Abbott Laboratories.
Other Diseases Therapeutics Markets Reports are Also Available:
- Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
- Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
- Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020
More new market research reports by the publisher can be found at GlobalData page.